|
|
Volumn 19, Issue 2, 2013, Pages 130-131
|
|
RNA editing enters the limelight in cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIZYME INHIBITOR 1;
CYCLIN D1;
MUTAGENIC AGENT;
ONCOPROTEIN;
ORNITHINE DECARBOXYLASE;
PROTEIN;
SORAFENIB;
UNCLASSIFIED DRUG;
ALCOHOL ABUSE;
ARTICLE;
CANCER GROWTH;
CANCER RISK;
CANCER SURVIVAL;
CARCINOGENESIS;
CELL PROLIFERATION;
CROSS REACTION;
DIABETES MELLITUS;
GENE MUTATION;
GENE THERAPY;
GENETIC ASSOCIATION;
HEPATITIS C;
HUMAN;
LIVER CANCER;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
METASTASIS;
NEOPLASM;
OBESITY;
POINT MUTATION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RNA EDITING;
RNA PROCESSING;
SOLID TUMOR;
ANIMALS;
CARCINOMA, HEPATOCELLULAR;
CARRIER PROTEINS;
HUMANS;
LIVER NEOPLASMS;
MALE;
RNA EDITING;
|
|
EID: 84873540802
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3072 Document Type: Article |
|
Times cited : (12)
|
|
References (13)
|
